
Oncology NEWS International
- Oncology NEWS International Vol 9 No 11
- Volume 9
- Issue 11
Peregrine Provides 3D Monte-Carlo-Based Dose Calculations for Radiation Therapy
The image shows the radiation therapy treatment plan for a seven-field conformal boost to the prostate, using Peregrine, a 3D Monte-Carlo-based dose calculation system. Monte Carlo simulates the trillions of radiation particles that enter the body during treatment and develops a detailed computerized map of the radiation dose the patient will receive. The technology, developed at the Lawrence Livermore National Laboratory and licensed to NOMOS Corporation, has received FDA clearance for marketing. Image courtesy of NOMOS and the Lawrence Livermore National Laboratory, Livermore, California.
The image shows the radiation therapy treatment plan for a seven-field conformal boost to the prostate, using Peregrine, a 3D Monte-Carlo-based dose calculation system. Monte Carlo simulates the trillions of radiation particles that enter the body during treatment and develops a detailed computerized map of the radiation dose the patient will receive. The technology, developed at the Lawrence Livermore National Laboratory and licensed to NOMOS Corporation, has received FDA clearance for marketing. Image courtesy of NOMOS and the Lawrence Livermore National Laboratory, Livermore, California.
Articles in this issue
over 25 years ago
Joe & Ali Torre Lead โTwo Against Oneโ Prostate Cancer Campaignover 25 years ago
Efforts to Reduce Tobacco Deaths May Fail in the Short Termover 25 years ago
Data Published for First-Line Irinotecanover 25 years ago
Manufacturing Capability a Factor in Success of New Biologicsover 25 years ago
Report Finds States Not Using Tobacco Funds for Preventionover 25 years ago
NCI Intramural Program Challenged to โReinvent Itselfโover 25 years ago
Surgery Supported for Recurring Colorectal Cancerover 25 years ago
Breast Cancer Stamp Funds $6.7 Million in 2-Year NCI Grantsover 25 years ago
Human Side of Cancer Offers Insights on Coping With the DiseaseNewsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.



































